TearClear
Latest round
- Series B
Last raised
- Aug 2020
Total raised
- $27M
Investors
- 3
About TearClear
Founded in 2015 and based in Copley, US, TearClear Corp. is a company that develops preservative-free topical ophthalmic drugs. The drugs are designed to be chemical filters to remove the preservatives from multi-dose eye drop bottles before the drug is used into the eye.
Who invested in TearClear
3 investors across 2 rounds
See all investors in TearClear
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about TearClear
Who invested in TearClear?
TearClear has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TearClear raised?
TearClear has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did TearClear last raise money?
TearClear's most recent round on record is a Series B, in Aug 2020.
What does TearClear do?
Founded in 2015 and based in Copley, US, TearClear Corp.
Where is TearClear headquartered?
TearClear is headquartered in Newport Beach, US.
Which VCs invest in companies like TearClear?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at TearClear's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like TearClear? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.